Advertisement

Development of an Oral Vaccine Against Enterotoxigenic Escherichia coli Diarrhea

  • Ann-Mari Svennerholm
  • Christina Åhrén
  • Christine Wennerås
  • Jan Holmgren
Part of the Federation of European Microbiological Societies Symposium Series book series (FEMS, volume 58)

Abstract

Although enterotoxigenic Escherichia coli (ETEC) is the most common cause of diarrhea in developing countries and in travelers to these areas, there is no ETEC vaccine available for use in humans. In developing countries ETEC diarrhea is mainly seen in children below 5 years and it has been estimated that as many as 650 million cases occur annually among these children, resulting in approximately 800.000 deaths [1]. ETEC is also the cause of 30–50% of all diarrheas in travelers to Latin America, Africa and Asia [1, 2, 3], i.e. between 2 and 3 million cases each year.

Keywords

Oral Immunization Cholera Vaccine COLI Diarrhea ETEC Strain ETEC Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R.E. Black, The epidemiology of cholera and enterotoxigenic E. coli diarrheal disease, in: “Development of vaccines and drugs against diarrhea,” 11th Nobel Conference, Stockholm, J. Holmgren, A. Lindberg and R. Mollby, eds., Studentlitteratur, Lund, p23 (1986).Google Scholar
  2. 2.
    R.L. Guerrant, Microbial toxins and diarrhoeal disease: introduction and overview, in: “Microbial toxins and diarrhoeal disease,” Ciba Foundation Symposium 112, Pitman, London, p1 (1985).Google Scholar
  3. 3.
    R. Steffen, Epidemiologic studies of travelers’ diarrhea, severe gastrointestinal infections, and cholera, Rev. of Infect. Dis. 8 (suppl 2):122 (1986).CrossRefGoogle Scholar
  4. 4.
    C. M. Åhrén and A.-M. Svennerholm, Synergestic protective effect of antibodies against Escherichia coli enterotoxin and colonization factor antigens. Infect. Immun. 38:74 (1982).PubMedGoogle Scholar
  5. 5.
    Y. Lopez-Vidal, J.J. Calva, A. Trujillo, A.P. de Léon, A. Ramos, A.-M. Svennerholm, and G.M. Ruiz-Palacios, Enterotoxins and adhesins of enterotoxigenic Escherichia coli: Are they risk factors for acute diarrhea in the community? J. Infect. Dis. 162:442 (1990).PubMedCrossRefGoogle Scholar
  6. 6.
    M.M. Levine, Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemoarrhagic and enteroadherent, J. Infect. Dis. 155:377 (1987).PubMedCrossRefGoogle Scholar
  7. 7.
    M.M. Levine, R.E. Black, M.L. Clements, D.R. Nalin, L. Cisneros, and R.A. Finkelstein, Volunteer studies in development of vaccines against cholera and enterotoxigenic Escherichia coli: a review, in: “Acute Enteric Infections in Children. New prospects for treatment and prevention”, T Holme, J. Holmgren, M.H. Merson, R. Möllby, eds., Elsevier/North-Holland Biomedical Press, Amsterdam, p 443 (1981).Google Scholar
  8. 8.
    C.M. Ahren and A.-M. Svennerholm, Experimental enterotoxin-induced Escherichia coli diarrhea and protection induced by previous infection with bacteria of the same adhesin or enterotoxin type. Infect. Immun. 50:255 (1985).PubMedGoogle Scholar
  9. 9.
    B.J. Stoll, A.-M. Svennerholm, L. Gothefors, D. Barua, S. Huda, and J. Holmgren, Local and systemic antibody reponses to naturally acquired enterotoxigenic Escherichia coli diarrhea in an endemic area, J. Infect. Dis. 153:527 (1986).PubMedCrossRefGoogle Scholar
  10. 10.
    L. Gothefors, C. Åhrén, B. Stoll, D.K. Barua, F. Ørskov, M. Salek, and A.-M. Svennerholm, Presence of colonization factor antigens on fresh isolates of fecal Escherichia coli. A prospective study, J. Infect. Dis. 152:1128 (1985).PubMedCrossRefGoogle Scholar
  11. 11.
    A.-M. Svennerholm, C. Wennerås, J. Holmgren, M.M. McConnell, and B. Rowe, Roles of different coli surface antigens of colonization factor antigen II in colonization by and protective immunogenicity of enterotoxigenic Escherichia coli, Infect. Immun. 58:341 (1990).PubMedGoogle Scholar
  12. 12.
    A.-M. Svennerholm, Y. Lopez-Vidal, J. Holmgren, M.M. McConnell, and B. Rowe, Role of PCF8775 antigen and its coli surface subcomponents for colonization, disease, and protective immunogenicity of enterotoxigenic Escherichia coli in rabbits. Infect. Immun. 56:523 (1988).PubMedGoogle Scholar
  13. 13.
    J. Clemens, D. Sack, J.R. Harris, J. Chakraborty, P.K. Neogy, B. Stanton, et al., Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. Infect. Dis. 158:372 (1988).CrossRefGoogle Scholar
  14. 14.
    A.-M. Svennerholm, J. Holmgren, and D. A. Sack, Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea. Vaccine 7:196 (1989).PubMedCrossRefGoogle Scholar
  15. 15.
    J. Sanchez, A.-M. Svennerholm, and J. Holmgren, Genetic fusion of a non-toxic heat-stable enterotoxin-related decapeptide antigen to cholera toxin B-subunit, FEBS Lett. 241:110 (1988).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Ann-Mari Svennerholm
    • 1
  • Christina Åhrén
    • 1
  • Christine Wennerås
    • 1
  • Jan Holmgren
    • 1
  1. 1.Department of Medical Microbiology and ImmunologyUniversity of GöteborgGöteborgSweden

Personalised recommendations